These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 11472272)

  • 21. PROMAXX inhaled insulin: safe and efficacious administration with a commercially available dry powder inhaler.
    Heise T; Brugger A; Cook C; Eckers U; Hutchcraft A; Nosek L; Rave K; Troeger J; Valaitis P; White S; Heinemann L
    Diabetes Obes Metab; 2009 May; 11(5):455-9. PubMed ID: 19236443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noninvasive insulin delivery: the great potential of cell-penetrating peptides.
    Kamei N; Nielsen EJ; Khafagy el-S; Takeda-Morishita M
    Ther Deliv; 2013 Mar; 4(3):315-26. PubMed ID: 23442079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concept, strategies, and feasibility of noninvasive insulin delivery.
    Cefalu WT
    Diabetes Care; 2004 Jan; 27(1):239-46. PubMed ID: 14693996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An effective absorption behavior of insulin for diabetic treatment following intranasal delivery using porous spherical calcium carbonate in monkeys and healthy human volunteers.
    Haruta S; Hanafusa T; Fukase H; Miyajima H; Oki T
    Diabetes Technol Ther; 2003; 5(1):1-9. PubMed ID: 12725701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent approaches in insulin delivery.
    Trehan A; Ali A
    Drug Dev Ind Pharm; 1998 Jul; 24(7):589-97. PubMed ID: 9876502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of particle size and aerosolization time on the metabolic effect of an inhaled insulin aerosol.
    Kapitza C; Heise T; Fishman RS; Shapiro DA; Gopalakrishnan V; Rave K; Bott S; Perera AD; Heinemann L
    Diabetes Technol Ther; 2004 Apr; 6(2):119-27. PubMed ID: 15117578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose-response relationships of inhaled insulin delivered via the Aerodose insulin inhaler and subcutaneously injected insulin in patients with type 2 diabetes.
    Kim D; Mudaliar S; Chinnapongse S; Chu N; Boies SM; Davis T; Perera AD; Fishman RS; Shapiro DA; Henry R
    Diabetes Care; 2003 Oct; 26(10):2842-7. PubMed ID: 14514589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhaled insulin: too soon to be forgotten?
    Zarogoulidis P; Papanas N; Kouliatsis G; Spyratos D; Zarogoulidis K; Maltezos E
    J Aerosol Med Pulm Drug Deliv; 2011 Oct; 24(5):213-23. PubMed ID: 21689020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral insulin and buccal insulin: a critical reappraisal.
    Heinemann L; Jacques Y
    J Diabetes Sci Technol; 2009 May; 3(3):568-84. PubMed ID: 20144297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Technosphere/Insulin--a new approach for effective delivery of human insulin via the pulmonary route.
    Pfützner A; Mann AE; Steiner SS
    Diabetes Technol Ther; 2002; 4(5):589-94. PubMed ID: 12450439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Waiting to inhale: noninjectable insulin, are we there yet?
    Hermansen K
    Curr Diab Rep; 2004 Oct; 4(5):335-41. PubMed ID: 15461897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current Therapeutic Strategy in the Nasal Delivery of Insulin: Recent Advances and Future Directions.
    Chen J; Hu L; Yang G; Hu Q
    Curr Pharm Biotechnol; 2018; 19(5):400-415. PubMed ID: 29921203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin inhalation--Pfizer/Nektar Therapeutics: HMR 4006, inhaled PEG-insulin--Nektar, PEGylated insulin--Nektar.
    Drugs R D; 2004; 5(3):166-70. PubMed ID: 15139780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. One-month subchronic toxicity study of cell-penetrating peptides for insulin nasal delivery in rats.
    Khafagy el-S; Kamei N; Nielsen EJ; Nishio R; Takeda-Morishita M
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):736-43. PubMed ID: 24060698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel drug delivery systems for insulin: clinical potential for use in the elderly.
    Belmin J; Valensi P
    Drugs Aging; 2003; 20(4):303-12. PubMed ID: 12641486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On employing a translationally controlled tumor protein-derived protein transduction domain analog for transmucosal delivery of drugs.
    Bae HD; Lee K
    J Control Release; 2013 Sep; 170(3):358-64. PubMed ID: 23791976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Inhaled insulin: a new route in the optimisation of glucose regulation].
    Luik PT; Veneman TF
    Ned Tijdschr Geneeskd; 2006 Apr; 150(15):833-8. PubMed ID: 16676512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipid emulsions as vehicles for enhanced nasal delivery of insulin.
    Mitra R; Pezron I; Chu WA; Mitra AK
    Int J Pharm; 2000 Sep; 205(1-2):127-34. PubMed ID: 11000549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Newer devices and improved formulations of inhaled insulin.
    Rashid J; Absar S; Nahar K; Gupta N; Ahsan F
    Expert Opin Drug Deliv; 2015 Jun; 12(6):917-28. PubMed ID: 25485886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of patients with diabetes mellitus by means of inhaled insulin].
    Simsek S; de Galan BE; Tack CJ; Heine RJ
    Ned Tijdschr Geneeskd; 2006 Apr; 150(15):829-32. PubMed ID: 16676511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.